Jefferies Keeps Their Buy Rating on Sotera Health (SHC)
Jefferies analyst David Windley maintained a Buy rating on Sotera Health (SHC) with a price target of $19.50. Windley, a 5-star analyst, has an average return of 9.3% and a 59.60% success rate. Sotera Health also received a Buy rating from BMO Capital's Sean Dodge, while Piper Sandler maintained a Hold rating.
Jefferies analyst David Windley maintained a Buy rating on Sotera Health today and set a price target of $19.50.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Windley is a 5-star analyst with an average return of 9.3% and a 59.60% success rate. Windley covers the Healthcare sector, focusing on stocks such as UnitedHealth, Charles River Labs, and Icon.
In addition to Jefferies, Sotera Health also received a Buy from BMO Capital’s Sean Dodge in a report issued on November 12. However, on November 5, Piper Sandler maintained a Hold rating on Sotera Health (NASDAQ: SHC).
